D.E. Shaw & Co’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1M | Buy |
445,678
+21,362
| +5% | +$718K | 0.01% | 1491 |
|
|
2025
Q4 | $18.2M | Buy |
424,316
+117,827
| +38% | +$4.44M | 0.01% | 1308 |
|
|
2025
Q3 | $8.68M | Buy |
+306,489
| New | +$9.17M | 0.01% | 1800 |
|
|
2023
Q1 | – | Sell |
-335,290
| Closed | -$5.03M | – | 4837 |
|
|
2022
Q4 | $5.03M | Sell |
335,290
-129,356
| -28% | -$1.19M | 0.01% | 2094 |
|
|
2022
Q3 | $5.48M | Buy |
464,646
+117,192
| +34% | +$1.59M | 0.01% | 1986 |
|
|
2022
Q2 | $3.93M | Buy |
347,454
+294,081
| +551% | +$5.91M | 0.01% | 2422 |
|
|
2022
Q1 | $1.6M | Buy |
53,373
+45,144
| +549% | +$1.22M | ﹤0.01% | 3521 |
|
|
2021
Q4 | $218K | Sell |
8,229
-4,666
| -36% | -$141K | ﹤0.01% | 4834 |
|
|
2021
Q3 | $468K | Buy |
+12,895
| New | +$508K | ﹤0.01% | 4128 |
|
|
2021
Q1 | – | Sell |
-4,667
| Closed | -$163K | – | 4464 |
|
|
2020
Q4 | $163K | Sell |
4,667
-9,299
| -67% | -$269K | ﹤0.01% | 3764 |
|
|
2020
Q3 | $335K | Sell |
13,966
-86,975
| -86% | -$2.14M | ﹤0.01% | 3402 |
|
|
2020
Q2 | $1.85M | Buy |
100,941
+60,525
| +150% | +$1.09M | ﹤0.01% | 2473 |
|
|
2020
Q1 | $630K | Sell |
40,416
-3,981
| -9% | -$84.7K | ﹤0.01% | 3078 |
|
|
2019
Q4 | $950K | Sell |
44,397
-9,965
| -18% | -$205K | ﹤0.01% | 3030 |
|
|
2019
Q3 | $1.02M | Buy |
54,362
+29,306
| +117% | +$605K | ﹤0.01% | 2818 |
|
|
2019
Q2 | $654K | Buy |
25,056
+15,953
| +175% | +$360K | ﹤0.01% | 2934 |
|
|
2019
Q1 | $234K | Sell |
9,103
-2,228
| -20% | -$50.9K | ﹤0.01% | 3336 |
|
|
2018
Q4 | $261K | Sell |
11,331
-12,048
| -52% | -$340K | ﹤0.01% | 3429 |
|
|
2018
Q3 | $750K | Sell |
23,379
-41,017
| -64% | -$1.23M | ﹤0.01% | 2867 |
|
|
2018
Q2 | $1.82M | Sell |
64,396
-17,808
| -22% | -$634K | ﹤0.01% | 2292 |
|
|
2018
Q1 | $2.91M | Sell |
82,204
-73,639
| -47% | -$2.95M | ﹤0.01% | 1771 |
|
|
2017
Q4 | $6.05M | Buy |
155,843
+4,723
| +3% | +$180K | 0.01% | 1363 |
|
|
2017
Q3 | $3.84M | Buy |
151,120
+15,591
| +12% | +$379K | 0.01% | 1576 |
|
|
2017
Q2 | $3.7M | Sell |
135,529
-26,336
| -16% | -$721K | 0.01% | 1559 |
|
|
2017
Q1 | $5.36M | Buy |
161,865
+16,349
| +11% | +$417K | 0.01% | 1247 |
|
|
2016
Q4 | $3.46M | Sell |
145,516
-46,663
| -24% | -$1.34M | 0.01% | 1572 |
|
|
2016
Q3 | $7.05M | Sell |
192,179
-49,836
| -21% | -$1.43M | 0.02% | 1088 |
|
|
2016
Q2 | $5.4M | Sell |
242,015
-14,471
| -6% | -$360K | 0.01% | 1238 |
|
|
2016
Q1 | $5.33M | Buy |
256,486
+12,486
| +5% | +$308K | 0.01% | 1226 |
|
|
2015
Q4 | $7.39M | Buy |
244,000
+14,650
| +6% | +$444K | 0.01% | 1153 |
|
|
2015
Q3 | $5.67M | Buy |
229,350
+4,877
| +2% | +$146K | 0.01% | 1313 |
|
|
2015
Q2 | $7.21M | Buy |
224,473
+16,875
| +8% | +$645K | 0.01% | 1220 |
|
|
2015
Q1 | $7.41M | Buy |
207,598
+51,866
| +33% | +$1.42M | 0.01% | 1137 |
|
|
2014
Q4 | $3.54M | Buy |
155,732
+4,598
| +3% | +$93K | 0.01% | 1825 |
|
|
2014
Q3 | $2.93M | Sell |
151,134
-14,315
| -9% | -$404K | 0.01% | 1939 |
|
|
2014
Q2 | $6.01M | Buy |
165,449
+3,175
| +2% | +$108K | 0.01% | 1481 |
|
|
2014
Q1 | $6.3M | Buy |
162,274
+13,064
| +9% | +$466K | 0.01% | 1399 |
|
|
2013
Q4 | $4.25M | Buy |
149,210
+39,664
| +36% | +$1.16M | 0.01% | 1824 |
|
|
2013
Q3 | $3.92M | Buy |
109,546
+26,702
| +32% | +$974K | 0.01% | 1825 |
|
|
2013
Q2 | $2.77M | Buy |
+82,844
| New | +$3.75M | 0.01% | 1824 |
|
Other funds holding RIGL
AC
VCM
